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Abstract
Background: The use of fat grafting as a reconstructive surgical option is becoming much more common.
Adipose-derived stem cells found in fat grafts are believed to facilitate wound healing via differentiation into
fibroblasts and keratinocytes and the release of pro-healing growth factors. Several small studies have shown
a positive effect of fat grafting in healing of wounds of a variety of aetiologies. When fat is combined with
autologous platelet-rich plasma (PRP), there may be enhanced healing effects. This may be due to the pro-angiogenic
and anti-inflammatory effects of PRP. We aim to synthesise the current evidence on combination fat grafting and PRP
for wound healing to establish the efficacy of this technique.
Methods/design: We will conduct a comprehensive literature search in the MEDLINE, EMBASE, CENTRAL, Science
Citation Index, and Google Scholar databases (up to July 2017) to identify studies on fat grafting and PRP for wound
healing. All primary studies and systematic reviews of these studies will be included, except case reports and case
series with fewer than three patients, to evaluate the outcome of fat grafting and PRP on wound healing either on its
own or when compared to other studies. Primary outcome measures are expected to be the proportion of
total wounds healed at 12 weeks and the average wound healing time (time for 100% re-epithelialisation).
Expected secondary outcome measures are the proportion of wounds achieving 50% wound healing, the type of wound
benefitting most from fat grafting, economic evaluation, health-related quality of life, and adverse events. Subgroup
analysis will be performed for the proportions of wounds healed based on wound aetiology.
Discussion: This review will provide robust evidence of the efficacy of fat grafting and PRP for wound healing. This is an
emerging technique, and this review is expected to guide clinical practice and ongoing research aimed at improving
wound care.
Systematic review registration: PROSPERO CRD42016049881
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Background
Wound management places a significant burden on
healthcare, costing the NHS in the UK billions of pounds
per annum [1]. Traditional wound management options
include regular dressings and skin grafting. Dressing man-
agement can often be a slow, time-consuming process
whereas skin grafts are associated with high-cost, donor-
site morbidity and occasionally hospital admission.
Fat grafting has become increasing popular in contour-
ing procedures over the last few decades [2]; however,
more recently, there is becoming an emphasis on its
regenerative potential. Adipose-derived stem cells or
MSCs found in fat are believed to facilitate healing
through differentiation into cells which affect wound
healing e.g. fibroblasts and keratinocytes [3]. They also
release pro-healing growth factors and anti-inflammatory
cytokines [4] as well as healing-related peptides such as
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leptin and adiponectin which together may enhance
wound healing [5]. Several small studies have shown that
autologous fat grafting may show significant healing qual-
ities in chronically scarred tissue after radiotherapy [6],
chronic wounds [7, 8], arterial ulcers [9], pressure ulcers
[10], and diabetic foot ulcers [11]. However, the evidence
remains limited with no randomised controlled trials
reported.
Platelet-rich plasma (PRP) is an autologous blood-
derived product enriched in platelets, growth factors,
chemokines, and cytokines. It is a reservoir of essential
growth factors, including platelet-derived growth factor,
vascular endothelial growth factor, transforming growth
factor-beta 1, and insulin-like growth factor which facili-
tate repair and healing. Platelet-derived biologic mediators
have two primary effects on wound healing: recruiting and
activating cells that affect wound healing and regulation of
angiogenesis [12, 13]. Platelets may also have antimicro-
bial and immune modulation properties which help to
reduce wound infection and facilitate healing [14]. Some
studies have found enhanced healing and reduced healing
time of split thickness skin grafts when used in combin-
ation with PRP [14–17] and improved healing when used
as the primary treatment for chronic wounds [18–20].
However, several higher level evidence studies have shown
no clear benefit for wound healing over conventional
treatments [21–23].
When fat and PRP are used in combination, there may
be increased survival of the fat graft which may in turn
increase the healing properties of the adipose-derived
stem cells. This is believed to be due to the pro-angiogenic
effects of PRP which allows early vascularisation of the fat
therefore reversing the early ischaemic phase of the graft
[24]. Another pro-survival effect may be the release of
anti-inflammatory chemokines which help reduce inflam-
mation and swelling which encourage degeneration of the
graft. Hypotheses also exist which suggest PRP may
provide nutrient support to the fat cells through its plasma
component and that the fibrin component allows forma-
tion of a scaffold for fat cells [25–27]. Some studies have
shown that when used in combination, PRP may increase
the maintenance of fat grafts for contouring procedures
[28–30]. However, the evidence for combination treatment
in wound healing is very limited [31] and the efficacy of
the technique is yet to be established.
An extensive search will be undertaken in the
MEDLINE (Ovid SP), EMBASE (OvidSP), Cochrane
Central Register of Controlled Trials (CENTRAL),
Science Citation Index, and Google Scholar databases
to identify systematic reviews and primary studies on
combination fat and PRP for wound healing. This
review will provide robust evidence of the efficacy of
fat grafting and PRP for wound healing. This is an
emerging technique, and this review is expected to
guide clinical practice and ongoing research aimed at
improving wound care.
Methods/design
Objective
This systematic review aims to summarise the best avail-
able evidence for the technique of combination fat grafting
and PRP in an effort to aid in establishing the efficacy of
this technique. This will be achieved by evaluating the use
of the technique in the clinical setting by measuring the
proportion of wounds healed and the mean wound
healing time (time to 100% re-epithelialisation).
General methods
This protocol has been registered with the PROSPERO
international prospective register of systematic reviews
(registration number CRD42016049881) and will be
reported adhering to the Preferred Reporting Items for Sys-
tematic Review and Meta-Analysis Protocols (PRISMA-P)
2015 statement [32]. The PRISMA-P checklist for this
study is included as an additional file (Additional file 1).
The final review will be reported following the PRISMA
statement. In the event of no randomised controlled trial
(RCT) being available to be included in the study,
this review will be reported according to the Meta-
Analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [33].
Search strategies
We will conduct searches of the MEDLINE (Ovid SP),
EMBASE (OvidSP), (CENTRAL), Science Citation Index
and Google Scholar databases from 1946 up to July 2017
to identify studies of relevance to this review. Publicly
available trial registers (ClinicalTrials.Gov and WHO
International Clinical Trials Registry Platform) will be
searched for all trials. The reference list of all articles
included will be crosschecked for further articles of rele-
vance. The search strategy will use a combination of text
word and Medical Subject Headings (MeSH) terms relat-
ing to the use of epidermal graft in treating wounds.
There will be no restriction by study design or outcomes
as the research questions are broad. No date or publica-
tion restriction will be applied. The initial search will be
conducted in English; if full articles not written in
English are identified and deemed to meet the criteria
for inclusion in the study, they will be translated into
English. A sample search strategy for MEDLINE
(OvidSP) is shown, and a similar strategy will be adapted
for use in other databases.
1. ([fat graft] OR [fat transfer] OR [adipose graft] OR
[adipose stem cell] OR [adipose derived stem cell]
OR [adipose tissue transplantation]) AND [wound
healing] AND ([platelet-rich-plasma] OR [PRP])
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Selection criteria
All human studies related to fat grafting and PRP for
treating wounds will be included.
Study design
All primary studies (excluding case reports or case series
with fewer than three patients) or systematic reviews of
these studies, which evaluate the outcome of fat grafting
and PRP for wound healing, will be included.
Type of participants
The participants are all patients (child and adult) with
wounds of any size or aetiology treated by a combination
of fat grafting and PRP.
Setting
Studies performed in any clinical setting will be included.
Intervention
Any technique of autologous fat harvesting which is
then combined with autologous PRP will be included.
Traditional techniques of fat harvesting include the
Coleman technique using cannula and syringe with or
without centrifuging, and the suction assisted liposuc-
tion technique. Both techniques may or may not include
infiltration of tumescent solution into the donor site.
Autologous PRP is harvested by obtaining a peripheral
blood sample and centrifuging this using a variety of dif-
ferent commercially available platelet purifying devices
to produce PRP. The two substances are mixed together
and infiltrated directly into and around the wound bed.
The amount injected varies between studies. There is no
evidence on a more efficacious standardised fat and PRP
technique. Information regarding the harvesting methods
for both fat and PRP, the volume of each substance
harvested, the volume applied, and the dressing used after
grafting will be documented.
Comparator
Studies comparing combination fat grafting and PRP to
any other wound management option will be included in
this review.
Outcome measures
The primary outcome measures will be the proportion of
wounds with complete healing at 12 weeks and the mean
wound healing time (to complete re-epithelialisation).
Secondary outcome measures will be the type of wound
benefitting most from fat grafting, economic evaluation,
health-related quality of life, and adverse events. Subgroup
analysis will be performed for the proportions of wounds
healed based on wound aetiology dependent on suffi-
cient data sets (e.g. vascular wounds, diabetic wounds,
traumatic wounds, burn wounds).
Exclusion criteria
The exclusion criteria will be case series of less than
three cases; studies describing the use of fat grafting and
PRP in cases not involving wound healing, studies not
reporting time or proportion for 100% wound healing,
studies in animal models, and studies describing only
the harvest technique without treatment outcome.
Study selection and data management
Study selection will be conducted in a two-stage process.
The titles and abstracts will initially be screened by two
reviewers, using pre-specified screening criteria, for
potential eligibility after excluding duplicate records. Next,
studies identified as relevant will undergo full-text review
by both reviewers. Any discrepancies between the
reviewers will be resolved by discussion or by referral to a
third reviewer. Any relevant non-English language articles
will be translated where necessary. The search results,
including abstracts, full-text articles, and record of the
reviewer’ s decisions, including reasons for exclusion, will
be recorded in Endnote X7 (Clarivate Analytics, USA).
Data extraction
The data from all full-text articles accepted for the final
analysis will be independently retrieved by two authors
using a standardised data extraction form. Any disagree-
ments and differences will be resolved by discussion or
referral to a third reviewer. Primary study authors will
be contacted if further information is needed or some
data are missing. The following data will be extracted:
– Study characteristics (authors, year of publication,
country of publication, study design)
– Patient demographics (number of subjects, gender,
mean age, comorbidities, number of wounds treated)
– Wound characteristics (wound aetiology, mean
wound duration, mean wound size, pre-grafting
wound quality)
– Characteristics of the intervention and control
group (wound bed preparation, fat grafting
technique, PRP harvesting technique, volume
harvested, volume applied, number of applications,
anaesthesia, use of antibiotics, wound dressing post-
grafting, bed rest post-grafting)
– Outcomes (mean wound healing time, proportion
of wounds with 100% healing, type of wounds
with 100% healing, number of failed grafts, the
type of wound benefitting most from fat grafting,
economic evaluation, health-related quality of life,
and adverse events)
– Length of follow-up
– Cost of fat grafting and PRP combination plus
dressings and follow-up
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– Health-related quality of life and patient-reported
outcome measures in patients managed with fat
and PRP
– Complications or adverse events occurring within
the study duration
– Statistical analysis model used
Assessment of risk of bias of included studies
Included studies will be critically appraised for methodo-
logical quality and risk of bias by two review authors
independently. Discrepancies will be resolved through
consensus or referral to a third reviewer if necessary.
The included studies are expected to all be observational
studies, with no RCTs. Should there be any RCTs, they
will be assessed according to the Cochrane Collaboration
Risk of Bias Assessment Tool [34]. The observational
cohort studies will be assessed using the Cochrane Risk
of Bias Assessment Tool for Non-Randomized Studies
of Interventions (ACROBAT-NRSI) [35]. This will evalu-
ate the risk of bias due to confounding, selection, meas-
urement, and interpretation. The quality of reporting
will be assessed using the Strengthening the Reporting
of Observational Studies in Epidemiology (STROBE)
checklist [36].
Data analysis and synthesis
The main outcome measure of the included studies will
be the pooled estimate of the proportions of wounds
healed at 12 weeks and the mean wound healing time
with corresponding 95% confidence intervals. Meta-
analysis will be performed should a sufficient number of
studies with consistent characteristics be found in terms
of study design and outcome reporting. We will explore
the sources of potential clinical and methodological
heterogeneity based on the study design, population,
intervention, and comparator characteristics and out-
comes. Statistical heterogeneity will be assessed using
the chi-square test and quantified with the I2 statistic.
The thresholds for interpretation of I2 will be in accord-
ance with the definitions presented in the Cochrane
Handbook for Systematic Reviews of Interventions [37].
Narrative synthesis will be performed in the event that
the meta-analysis is not appropriate. The narrative
synthesis will be grouped by the outcome of interest. As
several different fat grafting and PRP harvesting and
application techniques are expected to be used, the dif-
ference between the techniques will likely be synthesised
narratively. We also expect wounds from various aetiol-
ogies to be treated. The wounds will be broadly classified
into acute (<3 months in duration) and chronic
(≥3 months in duration), and the difference in outcome
will then be synthesised narratively. As the number of
studies included in the review in anticipated to be small,
the need for a sensitivity analysis is not expected.
Data synthesis will be performed using Review
Manager 5.3 provided by The Cochrane Collaboration
[37]. Should no RCT be available, a meta-analysis of
observational study will be performed using StatsDirect
statistical software (StatsDirect statistical software, version
2.8.0; StatsDirect, Altrincham, UK). The quality of evi-
dence will be rated using the Grading of Recommenda-
tions Assessment, Development and Evaluation (GRADE)
approach. The GRADE analysis will be performed as per
Cochrane Handbook for Systematic Reviews of Interven-
tions and applied for all outcomes. All studies will be
ranked based on the level of evidence and graded based
on quality of evidence by two authors independently. Data
will be presented in a summary of findings table using
GRADE-pro for the mean wound healing time and
proportion of wounds with 100% healing.
Discussion
This review aims to determine the efficacy of a combin-
ation treatment of fat grafting and platelet-rich plasma
for wound healing. This will be done by evaluating the
overall proportion of wounds completely healed with
this technique and the mean wound healing time.
Although there is some evidence that when used in
isolation these techniques improve wound healing, the
efficacy of them used in combination is currently
unclear. It is important to evaluate these two emerging
autologous treatments for their regenerative potential in
order to guide clinical practice and future research. To
our knowledge, this is the first systematic review to
evaluate the efficacy of this technique for wound
healing.
Limitations
We expect the sensitivity of our search to be limited by
the lack of MeSH terms for platelet-rich plasma and a
combination of fat grafting and PRP. We have included
a wide range of text word combinations to overcome
this. We also expect the small number of studies to limit
the potential for meta-analysis of studies although we
will continue to proceed with a narrative review in this
instance.
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